Sana Biotechnology (SANA) Amortizatization of Intangibles (2020 - 2026)
Sana Biotechnology's (SANA) quarterly Amortizatization of Intangibles came in at $2.5 million in Q1 2026, up 10.52% year-on-year from $2.2 million in Q1 2025, and up 3.22% quarter-over-quarter from $2.4 million in Q4 2025.
Sana Biotechnology (SANA) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Sana Biotechnology has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $2.5 million for Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $2.5 million, up 10.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.4 million (up 9.68% YoY), and the FY2025 annual result was $9.2 million, down 5.27% from the prior year.
- Amortizatization of Intangibles came in at $2.5 million for Q1 2026 at Sana Biotechnology, up from $2.4 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $3.4 million in Q2 2023 to a low of $2.0 million in Q2 2024.
- The 5-year median for Amortizatization of Intangibles is $2.6 million (2022), against an average of $2.7 million.
- Across the five-year window, Amortizatization of Intangibles surged 113.61% in 2022 and sank 39.75% in 2024, its largest moves.
- Sana Biotechnology's Amortizatization of Intangibles stood at $3.2 million in 2022, then fell by 0.4% to $3.2 million in 2023, then slumped by 32.59% to $2.2 million in 2024, then rose by 9.68% to $2.4 million in 2025, then climbed by 3.22% to $2.5 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.5 million (Q1 2026), $2.4 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Sana Biotechnology | 746.13 Mn | 746.13 Mn | - | 2.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.47 Mn |
| Mar 31, 2026 | 2.47 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Dec 31, 2025 | 2.39 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Mar 31, 2025 | 2.23 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Dec 31, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Sep 30, 2024 | 2.11 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.23 Mn |
| Dec 31, 2023 | 3.23 Mn |